Endo Boosts Urology Device Presence With $2.9 Billion AMS Bid
This article was originally published in The Gray Sheet
Executive SummaryEndo Pharmaceuticals has made its second big jump into the urology device space in less than a year, announcing April 11 that it will pay $2.9 billion in cash for American Medical Systems.
You may also be interested in...
Endo International plans to shutter its Astora Women's Health business unit – formerly part of American Medical Systems – this month due to ongoing legal concerns tied to the company’s vaginal mesh products. What’s unclear is what this means for the company’s investigational fecal incontinence treatment, which received unanimous support from an FDA advisory panel just days before the shutdown was announced.
The firm is expanding its leadership position in the urology space with its acquisition of American Medical Systems's men's health and prostate health units.
Endo Health Systems names president of American Medical Systems subsidiary. MAKO Surgical Senior VP of Sales & Marketing resigns. More people briefs.